Výsledky vyhledávání - "Mirella Memmi"

Akademický článek

Evidence of Carotid Atherosclerosis Vulnerability Regression in Real Life From Magnetic Resonance Imaging: Results of the MAGNETIC Prospective Study

Autor: Oronzo Catalano, Giulia Bendotti, Teresa L. Aloi, Alberto Ferrari Bardile, Mirella Memmi, Patrick Gambelli, Daniela Zanaboni, Alessandra Gualco, Emanuela Cattaneo, Antonio Mazza, Mauro Frascaroli, Esmeralda Eshja, Riccardo Bellazzi, Paolo Poggi, Giovanni Forni, Maria Teresa La Rovere

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 2 (2023)

Background Atherosclerosis vulnerability regression has been evidenced mostly in randomized clinical trials with intensive lipid‐lowering therapy. We aimed to demonstrate vulnerability regression in real life, with a comprehensive quantitative meth

Externí odkaz: https://doaj.org/article/40f95a60d3784b2ca6dc93ece95aea6d

Zobrazit plný text záznamu

Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers

Publikováno v: JAMA Cardiol
JAMA cardiology, 7(5), 504-512. American Medical Association
JAMA Cardiology, 7(5), 504-512. AMER MEDICAL ASSOC
Mazzanti, A, Kukavica, D, Trancuccio, A, Memmi, M, Bloise, R, Gambelli, P, Marino, M, Ortíz-Genga, M, Morini, M, Monteforte, N, Giordano, U, Keegan, R, Tomasi, L, Anastasakis, A, Davis, A M, Shimizu, W, Blom, N A, Santiago, D J, Napolitano, C, Monserrat, L & Priori, S G 2022, ' Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia Treated with β-Blockers ', JAMA cardiology, vol. 7, no. 5, pp. 504-512 . https://doi.org/10.1001/jamacardio.2022.0219

Patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) may experience life-threatening arrhythmic events (LTAEs) despite β-blocker treatment. Further complicating management, the role of implantable cardioverter defibrillator (IC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c929e7cc08bf8cf5e5f9c580b72e5d54
https://europepmc.org/articles/PMC8968697/

Zobrazit plný text záznamu

Role of CACNA1C in Brugada syndrome: Prevalence and phenotype of probands referred for genetic testing

Autor: Valeria Novelli, Mirella Memmi, Alberto Malovini, Andrea Mazzanti, Nian Liu, Ruan Yanfei, Rossana Bongianino, Marco Denegri, Nicola Monteforte, Raffaella Bloise, Massimo Morini, Carlo Napolitano

Publikováno v: Heart rhythm. 19(5)

Evidence for the role of the CACNA1C gene, which encodes for the α-subunit of the cardiac L-type calcium channel CaV1.2, as a cause of the BrS3 variant of Brugada syndrome (BrS) is contradictory.The purpose of this study was to define in a large BrS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3b790f35d83efe5dcb88e14a7f6272
https://pubmed.ncbi.nlm.nih.gov/34999275

Zobrazit plný text záznamu

Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy

Autor: Raffaella Bloise, Carlo Napolitano, Francesca La Rosa, Patrick Gambelli, Mirella Memmi, Antonio Curcio, Andrea Mazzanti, Alberto Malovini, Riccardo Bellazzi, Ciro Indolfi

Publikováno v: Heart rhythm. 18(10)

Background The genetic architecture of Brugada syndrome (BrS) is emerging as an increasingly complex area of investigation. The identification of genetically homogeneous populations can provide mechanistic insights and improve genotype-phenotype corr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47da19167fb82651ff9a4b94752cf564
https://pubmed.ncbi.nlm.nih.gov/34389501

Zobrazit plný text záznamu

CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases

Autor: Giovanna Nicora, Alberto Malovini, Silvia G. Priori, Patrick Gambelli, Carlo Napolitano, Mirella Memmi, Riccardo Bellazzi, Andrea Mazzanti, Ivan Limongelli

Publikováno v: Human Mutation. 39:1835-1846

Variant interpretation for the diagnosis of genetic diseases is a complex process. The American College of Medical Genetics and Genomics, with the Association for Molecular Pathology, have proposed a set of evidence-based guidelines to support varian

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822b3b674daaca3976b7692e24413429
https://doi.org/10.1002/humu.23665

Zobrazit plný text záznamu

Arrhythmogenic Right Ventricular Cardiomyopathy

Autor: Alessandro Faragli, Nicola Monteforte, Raffaella Bloise, Vincenzo Bagnardi, Carlo Napolitano, Nicoletta Orphanou, Riccardo Bellazzi, Kevin Ng, Massimo Morini, Guido Moro, Valeria Novelli, Oronzo Catalano, Patrick Gambelli, Silvia G. Priori, Riccardo Maragna, Valentina Tibollo, Elena Chiodaroli, Mirella Memmi, Andrea Mazzanti

Publikováno v: Journal of the American College of Cardiology. 68:2540-2550

Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a leading cause of sudden cardiac death, but its progression over time and predictors of arrhythmias are still being defined. Objectives This study sought to describe the clinical c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::02fe8a30d19be918a08985e188f38b43
https://doi.org/10.1016/j.jacc.2016.09.951

Zobrazit plný text záznamu

Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

Publikováno v: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

BACKGROUND Andersen-Tawil Syndrome type 1 (ATS1) is a rare arrhythmogenic disorder, caused by loss-of-function mutations in the KCNJ2 gene. We present here the largest cohort of patients with ATS1 with outcome data reported. OBJECTIVES This study sou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95db8f14bf6650a4244ac62d01a83ee2
https://pubmed.ncbi.nlm.nih.gov/32299590

Zobrazit plný text záznamu

Efficacy and Limitations of Quinidine in Patients With Brugada Syndrome

Autor: Andrea Mazzanti, Riccardo Bellazzi, Eleonora Pagan, Cristina Raimondo, Massimo Morini, Elisavietta Tenuta, Alice Maltret, Nicola Monteforte, Raffaella Bloise, Mirella Memmi, Barbara Colombi, Maira Marino, Vincenzo Bagnardi, Carlo Napolitano, Antonio Curcio, Samuele Frassoni, Valentina Tibollo, Silvia G. Priori

Publikováno v: Circulation: Arrhythmia and Electrophysiology. 12

Background:Quinidine at high dose is suggested as antiarrhythmic treatment in patients with Brugada Syndrome (BrS), but its efficacy to prevent life-threatening arrhythmic events (LAE) in this population is unproven and its use limited by frequent si

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbed3be9ba848bb035fa09cf59cc90c0
https://doi.org/10.1161/circep.118.007143

Zobrazit plný text záznamu

Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3

Autor: Paola Baiardi, Riccardo Maragna, Andrea Mazzanti, Susan P. Etheridge, Valeria Novelli, Mirella Memmi, Nicola Monteforte, Raffaella Bloise, Vincenzo Bagnardi, Silvia G. Priori, Alessandro Faragli, Carlo Napolitano

Publikováno v: Journal of the American College of Cardiology

Background Long QT syndrome type 3 (LQT3) is a lethal disease caused by gain-of-function mutations in the SCN5A gene, coding for the alpha-subunit of the sodium channel NaV1.5. Mexiletine is used to block late sodium current and to shorten QT interva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1de409a4fe9c53b9e4678435ef2df0

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání